Amanta Healthcare Limited

AMANTANotably above fair value

A 6-pillar fundamental profile. Each pillar scored 0–10.

5.0/10 composite
Prism for AMANTA.NS: composite 5.0 of 10, verdict Notably above fair valuePULSEQUALITYMOATSAFETYGROWTHVALUEBelow cohort range6.66.54.22.9Below cohort range

Pulse

· Neutral

Pulse data unavailable; neutral placeholder

Pulse tracks recent momentum in price, analyst revisions, and news sentiment. Higher means more positive near-term tailwinds.

Quality

6.6 · Moderate

Piotroski 7/9, ROCE 15.6%

Quality captures profitability, return on capital, and earnings consistency. Higher means a better business.

Moat

6.5 · Moderate

Narrow moat

Moat estimates durable competitive advantages — brand, scale, switching costs. Higher means more defensible.

Safety

4.2 · Weak

D/E 1.11, Int cov 1.5x

Safety looks at balance-sheet quality, leverage, and cash generation. Higher means lower financial risk.

Growth

2.9 · Weak

Rev CAGR 3.8%, EPS CAGR -42.0%

Growth reflects revenue and earnings expansion over recent years. Higher means faster compounding.

Value

· Insufficient peer data

Only 0 MoS peers in cohort

Value measures how the stock's price compares to its intrinsic worth. Higher means more discount to fair value.

Compare with another stock

Overlay AMANTA's prism against a peer.

Share this prism

Get the full analysis

Interactive DCF, sensitivity, peer comparison, and AI summary for AMANTA.

Full analysis →

Model estimate. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.

Amanta Healthcare Limited (AMANTA) Prism — YieldIQ